Headspace Analysis Software Module

The contract pertains to the supply and installation of Headspace Control Software designed for seamless integration with analytical instrumentation used in laboratory settings. This software module is intended to enhance the precision and efficiency of headspace analysis, a critical technique for detecting volatile compounds in samples, particularly within pharmaceutical, food, and environmental testing applications. The project requires full integration with existing analytical platforms, ensuring compatibility, real-time data handling, and compliance with regulatory standards for analytical accuracy and traceability. The solicitation is issued as a subcontract under the Food and Drug Administration, which operates under the Department of Health and Human Services, indicating that the software will support regulatory compliance and quality assurance functions. The NAICS code 511210 classifies this as software publishing, underscoring that the deliverable is a proprietary software product rather than a hardware upgrade. The response deadline is set for July 24, 2026, with the posting date of July 17, 2026, suggesting a compressed procurement timeline. The place of performance and point of contact information are not specified, implying that the contractor may perform work remotely or at multiple locations aligned with FDA’s analytical facilities.